ESR1 and breast carcinoma: An estimated 40,910 (40,460 women, 450 men) breast cancer death rate are expected by 2007, accounting 15% death with respect to other sites.1 Breast cancer is characterized by higher expression of epidermal growth factor receptor (EGFR) and estrogen/progesterone receptor (ER/PR).